Anti-CD325 APC

*Navarro P, Ruco L, Dejana E: Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol. 1998 Mar 23;140 (6) :1475-84., URL: https://pubmed.ncbi.nlm.nih.gov/9508779/, *Kim JB, Islam S, Kim YJ, Prudoff RS, Sass KM, Wheelock MJ, Johnson KR: N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol. 2000 Dec 11;151 (6) :1193-206., URL: https://pubmed.ncbi.nlm.nih.gov/11121435/, *Puch S, Armeanu S, Kibler C, Johnson KR, Müller CA, Wheelock MJ, Klein G: N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J Cell Sci. 2001 Apr;114 (Pt 8) :1567-77., URL: https://pubmed.ncbi.nlm.nih.gov/11282032/, *Wahl JK, Kim YJ, Cullen JM, Johnson KR, Wheelock MJ: N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane. J Biol Chem. 2003 May 9;278 (19) :17269-76., URL: https://pubmed.ncbi.nlm.nih.gov/12604612/, *Jaggi M, Wheelock MJ, Johnson KR: Differential displacement of classical cadherins by VE-cadherin. Cell Commun Adhes. 2002 Mar-Apr;9 (2) :103-15., URL: https://www.ncbi.nlm.nih.gov/pubmed/12487411

The mouse monoclonal antibody 8C11 recognizes an extracellular epitope of CD325 (N-cadherin), a transmembrane protein associated with actin cytoskeleton system, which is expressed mainly by neurons, osteoblasts, endothelial cells, and stem cells.